共 50 条
- [1] Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study (vol 25, pg e1930, 2020)ONCOLOGIST, 2021, 26 (03): : E523 - E523Frass, MichaelLechleitner, PeterGruendling, ChristaPirker, ClaudiaGrasmuk-Siegl, ErwinDomayer, JulianHochmair, MaximilianGaertner, KatharinaDuscheck, CorneliaMuchitsch, IlseMarosi, ChristineSchumacher, MichaelZoechbauer-Mueller, SabineManchanda, Raj K.Schrott, AndreaBurghuber, Otto
- [2] Expression of Concern: Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter StudyONCOLOGIST, 2022, 27 (12): : E985 - E985Frass, MichaelLechleitner, PeterGrundling, ChristaPirker, ClaudiaGrasmuk-Siegl, ErwinDomayer, JulianHochmair, MaximilianGaertner, KatharinaDuscheck, CorneliaMuchitsch, IlseMarosi, ChristineSchumacher, MichaelZochbauer-Muller, SabineManchanda, Raj K.Schrott, AndreaBurghuber, Otto
- [3] Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study (Publication with Expression of Concern)ONCOLOGIST, 2020, 25 (12): : E1930 - E1955Frass, MichaelLechleitner, PeterGruendling, ChristaPirker, ClaudiaGrasmuk-Siegl, ErwinDomayer, JulianHochmair, MaximilianGaertner, KatharinaDuscheck, CorneliaMuchitsch, IlseMarosi, ChristineSchumacher, MichaelZoechbauer-Mueller, SabineManchanda, Raj K.Schrott, AndreaBurghuber, Otto
- [4] Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapySPRINGERPLUS, 2015, 4Volovat, ConstantinBondarenko, Igor M.Gladkov, Oleg A.Elsaesser, ReinerBuchner, AntonBias, PeterMueller, Udo
- [5] Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled TrialCLINICAL CANCER RESEARCH, 2018, 24 (17) : 4089 - 4097Akiba, TadashiMorikawa, ToshiakiOdaka, MakotoNakada, TakeoKamiya, NorikiYamashita, MakotoYabe, MitsuoInagaki, TakuyaAsano, HisatoshiMori, ShoheiTsukamoto, YoUrashima, Mitsuyoshi
- [6] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1104 - 1109Han, BaohuiXiu, QingyuWang, HuiminShen, JieGu, AiqinLuo, YiBai, ChunxueGuo, ShuliangLiu, WenchaoZhuang, ZhixiangZhang, YangZhao, YizhuoJiang, LiyanZhou, JianyingJin, Xianqiao
- [7] A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA studyLUNG CANCER, 2020, 146 : 252 - 262Lu, ShunChen, GongyanSun, YupingSun, SanyuanChang, JianhuaYao, YuChen, ZhendongYe, FengLu, JunguoShi, JianhuaHe, JianxingLiu, XiaoqingZhang, YipingLiu, ZhihuaFang, JianCheng, YingHu, ChunhongMao, WeidongHu, YanpingGong, YoulingShan, LiYang, ZhixiongSong, YongLi, WeiBai, ChongWang, BuhaiMa, RuiZheng, ZhendongLiu, MingfangJie, ZhijunCao, LejieLiao, WangjunPan, HongmingHuang, DongningChen, YuanYang, JinjiQin, ShukuiMa, ShenglinLiang, LiLiu, ZheZhou, JianyingTao, MinHuang, YijiangQiu, FengHuang, YunchaoGuan, ShaPeng, MengyeSu, Weiguo
- [8] Anamorelin (ONO-7643) for the Treatment of Patients With Non-Small Cell Lung Cancer and Cachexia: Results From a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Japanese Patients (ONO-7643-04)CANCER, 2018, 124 (03) : 606 - 616Katakami, NobuyukiUchino, JunjiYokoyama, TakumaNaito, TateakiKondo, MasashiYamada, KouzoKitajima, HiromotoYoshimori, KozoSato, KazuhiroSaito, HiroshiAoe, KeisukeTsuji, TetsuyaTakiguchi, YuichiTakayama, KoichiKomura, NaoyukiTakiguchi, ToruEguchi, Kenji
- [9] A multicenter, randomized, double-blind, placebo-controlled phase III study of apatinib or placebo plus gefitinib as first-line treatment in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC)JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Zhao, HongyunZhang, ZhonghanLuo, FanMa, YuxiangFang, WenfengYang, YunpengZhang, YangHuang, YanZhang, Li
- [10] The effect of multivitamin and mineral complex on natural killer cell activity in surgically resected non-small cell lung cancer patients: A randomized, double-blind placebo-controlled studyRESPIROLOGY, 2023, 28 : 322 - 322Kim, JiwonChoi, Chang-MinKim, Hyeong RyulLee, Geun DongGil, MinchanLee, HyejaKim, Hye RimJi, WonjunLee, Seung Hyeun